Viewing Study NCT00560820


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-09 @ 2:45 AM
Study NCT ID: NCT00560820
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2007-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module